Market Cap 167.31M
Revenue (ttm) 9.99M
Net Income (ttm) -149.11M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,492.59%
Debt to Equity Ratio 0.00
Volume 1,136,100
Avg Vol 2,606,670
Day's Range N/A - N/A
Shares Out 93.47M
Stochastic %K 20%
Beta 2.60
Analysts Strong Sell
Price Target $9.88

Company Profile

Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and autoimmune diseases in the United States and internationally. The company's lead product candidate include CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma, refractory systemic lupus erythematosus, lupus nephritis...

Industry: Biotechnology
Sector: Healthcare
Phone: 510 982 6030
Address:
2929 7th Street, Suite 105, Berkeley, United States
ChicagoJoe20
ChicagoJoe20 Dec. 13 at 3:48 PM
0 · Reply
Peterson28
Peterson28 Dec. 12 at 3:43 PM
$CRBU So many 10k ask wall above 1.9. For few days already. Who is trying to cap the upside?
1 · Reply
pokerbreath
pokerbreath Dec. 11 at 7:33 PM
0 · Reply
GenomicEquities
GenomicEquities Dec. 10 at 2:48 PM
$CRBU has anyone heard anything at all or maybe read something others might have missed? They still have time to update investors on P3. Hopefully they are quietly finalizing some sort of deal.
1 · Reply
Market_Luther_Kang
Market_Luther_Kang Dec. 9 at 12:22 PM
$CRBU Really can't wait to see Caribou take off. https://x.com/awisejester/status/1998359787604766858?s=46
1 · Reply
3DBuilds
3DBuilds Dec. 8 at 9:50 PM
0 · Reply
pokerbreath
pokerbreath Dec. 8 at 8:56 PM
0 · Reply
ShadowBanningIsBad
ShadowBanningIsBad Dec. 8 at 8:15 PM
$ALT $CRBU step 2 is dump it.
0 · Reply
RocroBio
RocroBio Dec. 8 at 8:01 PM
0 · Reply
IwannaRetire
IwannaRetire Dec. 8 at 3:05 PM
$CRBU Good session on Sat morn for the ASH KOL. My fav part from the Q&A, paraphrasing here .... Q: If the results from Phase 1 hold in Phase 3, is there a need for Autologous after this? A: Very emphatic "No". That kind of sums it up. Now she needs to get the story out. Meet with more analysts, go to more conferences, go on a road show, get more press coverage. Get out to investor community. Re build bridges and get this news out. They need to update their monthly deck with either updates on distribution partnerships, or with a path to profitability without hitting the pre-authorized shelf offering. Either one of those will move the needs. The science works, now go tell the story.
0 · Reply
Latest News on CRBU
ChicagoJoe20
ChicagoJoe20 Dec. 13 at 3:48 PM
0 · Reply
Peterson28
Peterson28 Dec. 12 at 3:43 PM
$CRBU So many 10k ask wall above 1.9. For few days already. Who is trying to cap the upside?
1 · Reply
pokerbreath
pokerbreath Dec. 11 at 7:33 PM
0 · Reply
GenomicEquities
GenomicEquities Dec. 10 at 2:48 PM
$CRBU has anyone heard anything at all or maybe read something others might have missed? They still have time to update investors on P3. Hopefully they are quietly finalizing some sort of deal.
1 · Reply
Market_Luther_Kang
Market_Luther_Kang Dec. 9 at 12:22 PM
$CRBU Really can't wait to see Caribou take off. https://x.com/awisejester/status/1998359787604766858?s=46
1 · Reply
3DBuilds
3DBuilds Dec. 8 at 9:50 PM
0 · Reply
pokerbreath
pokerbreath Dec. 8 at 8:56 PM
0 · Reply
ShadowBanningIsBad
ShadowBanningIsBad Dec. 8 at 8:15 PM
$ALT $CRBU step 2 is dump it.
0 · Reply
RocroBio
RocroBio Dec. 8 at 8:01 PM
0 · Reply
IwannaRetire
IwannaRetire Dec. 8 at 3:05 PM
$CRBU Good session on Sat morn for the ASH KOL. My fav part from the Q&A, paraphrasing here .... Q: If the results from Phase 1 hold in Phase 3, is there a need for Autologous after this? A: Very emphatic "No". That kind of sums it up. Now she needs to get the story out. Meet with more analysts, go to more conferences, go on a road show, get more press coverage. Get out to investor community. Re build bridges and get this news out. They need to update their monthly deck with either updates on distribution partnerships, or with a path to profitability without hitting the pre-authorized shelf offering. Either one of those will move the needs. The science works, now go tell the story.
0 · Reply
Windytimes
Windytimes Dec. 8 at 2:56 PM
$CRBU mind numbing
1 · Reply
3DBuilds
3DBuilds Dec. 8 at 2:03 PM
0 · Reply
steven1x
steven1x Dec. 8 at 3:50 AM
$CRBU did A1 miss anything https://copilot.microsoft.com/shares/VQxAWLRD4dFSQ1zRjQhah
0 · Reply
pokerbreath
pokerbreath Dec. 8 at 2:44 AM
$CRBU https://www.tipranks.com/news/blurbs/bank-of-america-securities-sticks-to-their-buy-rating-for-caribou-biosciences-crbu-blurbs-2?utm_source=webullapp.com&utm_medium=referral#google_vignette
0 · Reply
Windytimes
Windytimes Dec. 7 at 5:36 PM
$CRBU no interviews from @biotechtv with Rachel? I would think Brad would like to talk to Rachel - that was pretty solid big news. What about the @firecebiotech? They were very critical of a@crbu make or break decision of dropping CB-012 and other assets to focus on CB-010 and 011, I guess cats got their tongue, or $CRBU is being strategically silent.
0 · Reply
Windytimes
Windytimes Dec. 7 at 5:25 PM
$CRBU do we have any news Insight from the conference? I haven’t seen anything
1 · Reply
3DBuilds
3DBuilds Dec. 6 at 8:32 PM
$CRBU $EDIT $NTLA $PRME Caribou Biosciences CRISPR plants and animals patents 💯 Europe is now letting CRISPR plants and animals this is huge 💰 🌎
0 · Reply
NicaInvest85
NicaInvest85 Dec. 5 at 6:10 PM
$CRBU Imagine the therapeutics and cures in the making with Gene Editing.
0 · Reply
NicaInvest85
NicaInvest85 Dec. 5 at 6:09 PM
$CRBU This is the frustration with Biotech companies just waiting for data results. CRBU has positive data but it has to go through the process. Unfortunately we have an admin that doesn’t believe in science. But Gene Editing is the next frontier in medicine and CRBU is in the forefront.
0 · Reply
haydenjc
haydenjc Dec. 5 at 3:32 PM
$CRBU don’t think it has the ability to hit 2 this month.
0 · Reply
haydenjc
haydenjc Dec. 5 at 3:03 PM
$CRBU so this evening, will be back. SMH
0 · Reply
haydenjc
haydenjc Dec. 5 at 2:59 PM
$CRBU too damn stagnant. Be back when in 1.70’s
0 · Reply